View all jobs
Clinical Trial Participation Opportunity: Advancing Alzheimer’s Research
Physicians are invited to participate in a groundbreaking Alzheimer’s disease clinical trial initiative that leverages a streamlined, patient-focused recruitment and prescreening model. This approach is designed to accelerate trial enrollment, reduce screen failure rates, and improve the overall patient and physician experience.
This initiative uses advanced blood-based biomarker testing to prescreen patients 55 and older who show signs of mild cognitive impairment or early dementia. The testing identifies amyloid plaques—key indicators of Alzheimer’s disease—with accuracy comparable to PET scans and CSF analysis, but with significantly less burden on the patient and care team.
Key advantages for participating physicians include:
Please visit our website for additional information: www.FosterCrown.com
US1673: Foster Crown: 1099 Direct Contract, Telemedicine Opportunity for Clinical Trial Participation
Telemedicine, Remote, many · Healthcare- Any Licensure accepted -- Multiple State licenses required
- Flexible Schedule – No set schedule, work remotely on your own terms
- Join a cutting-edge clinical trial with a national group dedicated to patient-focused care
- Additional Opportunity for an Independent CMO, Assisting to Grow and Develop this National Program
Clinical Trial Participation Opportunity: Advancing Alzheimer’s Research
Physicians are invited to participate in a groundbreaking Alzheimer’s disease clinical trial initiative that leverages a streamlined, patient-focused recruitment and prescreening model. This approach is designed to accelerate trial enrollment, reduce screen failure rates, and improve the overall patient and physician experience.
This initiative uses advanced blood-based biomarker testing to prescreen patients 55 and older who show signs of mild cognitive impairment or early dementia. The testing identifies amyloid plaques—key indicators of Alzheimer’s disease—with accuracy comparable to PET scans and CSF analysis, but with significantly less burden on the patient and care team.
Key advantages for participating physicians include:
- Reduced Screen Failures: Patients are tested for relevant biomarkers before site visits, ensuring only qualified candidates are referred for enrollment.
- Efficient Enrollment: A digital consent process and mobile phlebotomy options minimize delays and improve patient compliance.
- Concierge Support: Patients are guided throughout the prescreening and enrollment process, minimizing administrative tasks for your team.
- Improved Patient Experience: Blood-based testing is less invasive and more accessible, helping to improve participation rates and retention.
- Expanded Access: The model supports remote testing and outreach, enabling you to serve a broader and more diverse population.
Please visit our website for additional information: www.FosterCrown.com